Distinguishing Cellulitis From Acute Gout
Cellulitis is a diffuse, superficial spreading skin infection that causes rapidly spreading erythema with warmth and tenderness, with or without systemic symptoms. [1,2] Gout flares can mimic cellulitis through warmth, erythema, and pain over the involved joint or periarticular skin. [3]
Clinical Features Supporting Cellulitis
- Rapidly spreading erythema with swelling, tenderness, and warmth is typical. [1]
- Systemic features (for example, fever) can occur with cellulitis. [2]
- Absence of a discrete joint-centered pattern favors cellulitis over gout. [1,2]
Clinical Features Supporting Gout
- Gout flares commonly present as acute inflammatory arthritis, which can produce warmth, erythema, and pain around the affected joint that may be mistaken for cellulitis. [3]
- Diagnostic confirmation of gout is based on identification of monosodium urate crystals in synovial fluid or bursal aspirate. [4]
- Uncertainty remains common when synovitis and cellulitis are both plausible. [4,5]
Diagnostic Testing to Resolve Diagnostic Uncertainty
- Synovial fluid aspiration with polarized light microscopy for monosodium urate crystals is the confirmatory diagnostic test for gout. [4]
- When joint aspiration cannot be performed or the diagnosis of gout remains uncertain, imaging of the affected joint with ultrasound, X-ray, or dual-energy CT should be considered. [5]
- When cellulitis is suspected, microbiologic evaluation is generally reserved for situations with severe systemic features or unusual predisposing factors, where blood cultures and other studies may be indicated. [1]
Initial Management for Suspected Cellulitis
- Nonpurulent cellulitis is stratified by severity. Mild nonpurulent infection corresponds to typical cellulitis/erysipelas without a focus of purulence. [1]
- Outpatient management is recommended for patients without SIRS, altered mental status, or hemodynamic instability. [1]
- Systemic antibiotics are indicated for cellulitis with systemic signs of infection. [1]
- Antimicrobial selection should target streptococci for mild nonpurulent cellulitis. [1]
- Empiric coverage for MRSA is recommended for cellulitis associated with penetrating trauma, evidence of MRSA elsewhere, nasal MRSA colonization, injection drug use, or SIRS. [1]
- Hospitalization is recommended when there is concern for deeper or necrotizing infection, poor adherence to therapy, severe immunocompromise, or clinically concerning features. [1]
- Treatment duration is recommended as 5 days for cellulitis, with extension if infection has not improved within this time period. [1]
Initial Management for Confirmed or Strongly Suspected Acute Gout Flare
- First-line anti-inflammatory therapy for acute gout flares should include oral colchicine, NSAIDs, or glucocorticoids based on patient factors and preferences. [6]
Monotherapy vs Combination Therapy
- Cellulitis management should center on antimicrobial therapy matched to severity and MRSA risk. [1]
- Acute gout flare management should center on selecting one of the recommended anti-inflammatory agents (colchicine, NSAID, or glucocorticoid) for initial treatment. [6]
- Combined antimicrobial and anti-inflammatory strategies should be reserved for clinical situations where both diagnoses are concurrently supported, because diagnostic uncertainty is addressed first with testing when feasible. [1,4,5]
Treatment Escalation and Reassessment
- Clinical improvement within the expected early course should be assessed. Treatment should be extended when improvement has not occurred by 5 days for cellulitis. [1]
- When initial management is started for cellulitis, escalation to inpatient-level care should be considered if features evolve toward deeper or necrotizing infection or systemic instability. [1]
- When gout remains uncertain, definitive evaluation using aspiration or appropriate imaging should be pursued when feasible to prevent inappropriate antimicrobial or anti-inflammatory escalation. [4,5]